BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 31411085)

  • 1. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.
    Schneider SM; Sansom GT; Guo LJ; Furuya S; Weeks BR; Kornegay JN
    Front Vet Sci; 2021; 8():759585. PubMed ID: 35252412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected acute myocardial infarction in a dystrophin-deficient dog.
    Schneider SM; Coleman AE; Guo LJ; Tou S; Keene BW; Kornegay JN
    Neuromuscul Disord; 2016 Jun; 26(6):361-6. PubMed ID: 27105608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in Left Ventricular Contractile Function Develops in Puppies With Duchenne Muscular Dystrophy.
    Ghaleh B; Barthélemy I; Sambin L; Bizé A; Hittinger L; Blot S; Su JB
    J Am Soc Echocardiogr; 2020 Jan; 33(1):120-129.e1. PubMed ID: 31611157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of disease severity in a Canine Model of Duchenne Muscular Dystrophy: Classification of Quantitative MRI.
    Eresen A; Alic L; Kornegay J; Ji JX
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():648-651. PubMed ID: 30440480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture as an imaging biomarker for disease severity in golden retriever muscular dystrophy.
    Eresen A; Alic L; Birch SM; Friedeck W; Griffin JF; Kornegay JN; Ji JX
    Muscle Nerve; 2019 Mar; 59(3):380-386. PubMed ID: 30461036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.
    Yugeta N; Urasawa N; Fujii Y; Yoshimura M; Yuasa K; Wada MR; Nakura M; Shimatsu Y; Tomohiro M; Takahashi A; Machida N; Wakao Y; Nakamura A; Takeda S
    BMC Cardiovasc Disord; 2006 Dec; 6():47. PubMed ID: 17140458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.
    Hawkins EC; Bettis AK; Kornegay JN
    Neuromuscul Disord; 2020 Nov; 30(11):930-937. PubMed ID: 33071066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Doppler assessment of diastolic and systolic alterations of radial and longitudinal left ventricular motions in Golden Retrievers during the preclinical phase of cardiomyopathy associated with muscular dystrophy.
    Chetboul V; Carlos C; Blot S; Thibaud JL; Escriou C; Tissier R; Retortillo JL; Pouchelon JL
    Am J Vet Res; 2004 Oct; 65(10):1335-41. PubMed ID: 15524319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy.
    Su JB; Cazorla O; Blot S; Blanchard-Gutton N; Ait Mou Y; Barthélémy I; Sambin L; Sampedrano CC; Gouni V; Unterfinger Y; Aguilar P; Thibaud JL; Bizé A; Pouchelon JL; Dabiré H; Ghaleh B; Berdeaux A; Chetboul V; Lacampagne A; Hittinger L
    Cardiovasc Res; 2012 Jul; 95(1):86-96. PubMed ID: 22562664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
    Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
    Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
    Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of rimeporide on left ventricular function in golden retriever muscular dystrophy dogs.
    Ghaleh B; Barthélemy I; Wojcik J; Sambin L; Bizé A; Hittinger L; Tran TD; Thomé FP; Blot S; Su JB
    Int J Cardiol; 2020 Aug; 312():89-95. PubMed ID: 32199683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Grange RW
    Methods Mol Biol; 2011; 709():105-23. PubMed ID: 21194024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.